ArticleNeuroscience letters2023

BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT

Georgina Perez-Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.